J-code: Drugs administered other than oral method; chemotherapy drugs Drugs administered other than oral method; chemotherapy drugs
1,255 codes
Billing context
J-codes are permanent national codes for drugs and biologicals — most often clinician-administered (buy-and-bill) products paid under Medicare Part B — plus certain immunosuppressive, inhalation (via DME), and oral anticancer/antiemetic drugs. Units are reported in multiples of the dosage in the code descriptor.
| Code | Long descriptor | Payment limit (Q4 2026) | Added | Status |
|---|---|---|---|---|
| J1598 | Injection, glycopyrrolate (fresenius kabi), not therapeutically equivalent to j1596, 0.1 mg | $1.904per 0.1 MG | Jul 1, 2024 | Active |
| J1599 | Injection, immune globulin, intravenous, non-lyophilized (e.g., liquid), not otherwise specified, 500 mgNOC / NOS | — | Jan 1, 2011 | Active |
| J1600 | Injection, gold sodium thiomalate, up to 50 mg | — | Jan 1, 1982 | Active |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | $10.978per 1 MG | Jan 1, 2014 | Active |
| J1610 | Injection, glucagon hydrochloride, per 1 mg | $105.492per 1 MG | Jan 1, 1986 | Active |
| J1611 | Injection, glucagon hydrochloride (fresenius kabi), not therapeutically equivalent to j1610, per 1 mg | $134.892per 1 MG | Jan 1, 2023 | Active |
| J1612 | Injection, glucagon (gvoke), 0.01 mg | $1.799per 0.01 MG | Oct 1, 2025 | Active |
| J1620 | Injection, gonadorelin hydrochloride, per 100 mcg | — | Jan 1, 1982 | Ended Dec 31, 2025 |
| J1626 | Injection, granisetron hydrochloride, 100 mcg | $0.160per 100 MCG | Jan 1, 1998 | Active |
| J1627 | Injection, granisetron, extended-release, 0.1 mg | $2.907per 0.1 MG | Jan 1, 2018 | Active |
| J1628 | Injection, guselkumab, 1 mg | $66.998per 1 MG | Jan 1, 2019 | Active |
| J1630 | Injection, haloperidol, up to 5 mg | $0.632per 5 MG | Jan 1, 1986 | Active |
| J1631 | Injection, haloperidol decanoate, per 50 mg | $4.847per 50 MG | Jan 1, 1989 | Active |
| J1632 | Injection, brexanolone, 1 mg | — | Oct 1, 2020 | Active |
| J1640 | Injection, hemin, 1 mg | $36.050per 1 MG | Jan 1, 2006 | Active |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | $0.018per 10 UNITS | Jan 1, 1995 | Active |
| J1643 | Injection, heparin sodium (pfizer), not therapeutically equivalent to j1644, per 1000 units | $2.248per 1000 UNITS | Jan 1, 2023 | Active |
| J1644 | Injection, heparin sodium, per 1000 units | $0.201per 1000 UNITS | Jan 1, 1995 | Active |
| J1645 | Injection, dalteparin sodium, per 2500 iu | $45.668per 2500 IU | Jan 1, 1997 | Active |
| J1650 | Injection, enoxaparin sodium, 10 mg | $0.497per 10 MG | Jan 1, 1996 | Active |
| J1652 | Injection, fondaparinux sodium, 0.5 mg | $0.798per 0.5 MG | Jan 1, 2003 | Active |
| J1655 | Injection, tinzaparin sodium, 1000 iu | — | Jan 1, 2002 | Ended Dec 31, 2025 |
| J1670 | Injection, tetanus immune globulin, human, up to 250 units | $600.635per 250 UNITS | Jan 1, 1986 | Active |
| J1675 | Injection, histrelin acetate, 10 micrograms | — | Jan 1, 2006 | Active |
| J1700 | Injection, hydrocortisone acetate, up to 25 mg | — | Jan 1, 1982 | Active |
| J1710 | Injection, hydrocortisone sodium phosphate, up to 50 mg | — | Jan 1, 1982 | Ended Dec 31, 2025 |
| J1720 | Injection, hydrocortisone sodium succinate, up to 100 mg | $23.149per 100 MG | Jan 1, 1982 | Active |
| J1725 | Injection, hydroxyprogesterone caproate, 1 mg | — | Jan 1, 2012 | Ended Dec 31, 2017 |
| J1726 | Injection, hydroxyprogesterone caproate, (makena), 10 mg | — | Jan 1, 2018 | Active |
| J1729 | Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mgNOC / NOS | — | Jan 1, 2018 | Active |
| J1730 | Injection, diazoxide, up to 300 mg | — | Jan 1, 1982 | Active |
| J1736 | Injection, meloxicam (delova), 1 mg | — | Jan 1, 2026 | Active |
| J1737 | Injection, meloxicam (azurity), 1 mg | $1.060per 1 MG | Jan 1, 2026 | Active |
| J1738 | Injection, meloxicam, 1 mg | — | Oct 1, 2020 | Active |
| J1740 | Injection, ibandronate sodium, 1 mg | $43.680per 1 MG | Jan 1, 2007 | Active |
| J1741 | Injection, ibuprofen, 100 mg | $3.268per 100 MG | Jan 1, 2013 | Active |
| J1742 | Injection, ibutilide fumarate, 1 mg | — | Jan 1, 1998 | Active |
| J1743 | Injection, idursulfase, 1 mg | $572.171per 1 MG | Jan 1, 2008 | Active |
| J1744 | Injection, icatibant, 1 mg | — | Jan 1, 2013 | Active |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | $29.856per 10 MG | Jan 1, 2000 | Active |
| J1746 | Injection, ibalizumab-uiyk, 10 mg | $79.997per 10 MG | Jan 1, 2019 | Active |
| J1747 | Injection, spesolimab-sbzo, 1 mg | $65.728per 1 MG | Apr 1, 2023 | Active |
| J1748 | Injection, infliximab-dyyb (zymfentra), 10 mg | — | Jul 1, 2024 | Active |
| J1749 | Injection, iloprost, 0.1 mcg | $5.651per 0.1 MCG | Oct 1, 2024 | Active |
| J1750 | Injection, iron dextran, 50 mg | $19.005per 50 MG | Dec 31, 2005 | Active |
| J1756 | Injection, iron sucrose, 1 mg | $0.224per 1 MG | Jan 1, 2003 | Active |
| J1757 | Injection, tividenofusp alfa-eknm, 1 mg | — | Oct 1, 2026 | Active |
| J1786 | Injection, imiglucerase, 10 units | $43.203per 10 UNITS | Jan 1, 2011 | Active |
| J1790 | Injection, droperidol, up to 5 mg | $5.348per up to 5 MG | Jan 1, 1982 | Active |
| J1800 | Injection, propranolol hcl, up to 1 mg | — | Jan 1, 1982 | Active |
| J1805 | Injection, esmolol hydrochloride, 10 mg | $0.246per 10 MG | Jul 1, 2023 | Active |
| J1806 | Injection, esmolol hydrochloride (wg critical care), not therapeutically equivalent to j1805, 10 mg | $0.196per 10 MG | Jul 1, 2023 | Active |
| J1807 | Injection, ethacrynate sodium, 1 mg | — | Oct 1, 2025 | Active |
| J1808 | Injection, folic acid, 0.1 mg | $0.053per 0.1 MG | Apr 1, 2025 | Active |
| J1809 | Injection, fosdenopterin, 0.1 mg | $17.736per 0.1 MG | Oct 1, 2025 | Active |
| J1810 | Injection, droperidol and fentanyl citrate, up to 2 ml ampule | — | Jan 1, 1982 | Ended Mar 31, 2025 |
| J1811 | Insulin (fiasp) for administration through dme (i.e., insulin pump) per 50 units | $1.181per 50 UNITS | Jul 1, 2023 | Active |
| J1812 | Insulin (fiasp), per 5 units | — | Jul 1, 2023 | Active |
| J1813 | Insulin (lyumjev) for administration through dme (i.e., insulin pump) per 50 units | $3.903per 50 UNITS | Jul 1, 2023 | Active |
| J1814 | Insulin (lyumjev), per 5 units | — | Jul 1, 2023 | Active |
| J1815 | Injection, insulin, per 5 units | — | Jan 1, 2003 | Active |
| J1817 | Insulin for administration through dme (i.e., insulin pump) per 50 units | $3.116per 50 UNITS | Jan 1, 2003 | Active |
| J1818 | Injection, pegzilarginase-nbln, 0.05 mg | — | Oct 1, 2026 | Active |
| J1823 | Injection, inebilizumab-cdon, 1 mg | $511.573per 1 MG | Jan 1, 2021 | Active |
| J1826 | Injection, interferon beta-1a, 30 mcg | — | Jan 1, 2011 | Active |
| J1830 | Injection, interferon beta-1b, 0.25 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | — | Jan 1, 1982 | Active |
| J1833 | Injection, isavuconazonium, 1 mg | — | Jan 1, 2016 | Active |
| J1834 | Injection, isoniazid, 1 mg | — | Oct 1, 2025 | Active |
| J1835 | Injection, itraconazole, 50 mg | — | Jan 1, 2002 | Active |
| J1836 | Injection, metronidazole, 10 mg | $0.034per 10 MG | Jul 1, 2023 | Active |
| J1837 | Injection, posaconazole, 1 mg | $0.385per 1 MG | Jan 1, 2026 | Active |
| J1840 | Injection, kanamycin sulfate, up to 500 mg | — | Jan 1, 1982 | Ended Mar 31, 2024 |
| J1850 | Injection, kanamycin sulfate, up to 75 mg | — | Jan 1, 1982 | Ended Mar 31, 2024 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | $0.569per 15 MG | Jan 1, 1993 | Active |
| J1890 | Injection, cephalothin sodium, up to 1 gram | — | Jan 1, 1982 | Ended Mar 31, 2025 |
| J1920 | Injection, labetalol hydrochloride, 5 mg | $0.588per 5 MG | Jul 1, 2023 | Active |
| J1921 | Injection, labetalol hydrochloride (hikma), not therapeutically equivalent to j1920, 5 mg | $0.874per 5 MG | Jul 1, 2023 | Active |
| J1930 | Injection, lanreotide, 1 mg | $41.688per 1 MG | Jan 1, 2009 | Active |
| J1931 | Injection, laronidase, 0.1 mg | $41.498per 0.1 MG | Jan 1, 2005 | Active |
| J1932 | Injection, lanreotide, (cipla), 1 mg | $20.330per 1 MG | Oct 1, 2022 | Active |
| J1938 | Injection, furosemide, 1 mg | $0.018per 1 MG | Apr 1, 2025 | Active |
| J1939 | Injection, bumetanide, 0.5 mg | $0.493per 0.5 MG | Jan 1, 2024 | Active |
| J1940 | Injection, furosemide, up to 20 mg | — | Jan 1, 1982 | Ended Mar 31, 2025 |
| J1941 | Injection, furosemide (furoscix), 20 mg | — | Jul 1, 2023 | Ended Sep 30, 2026 |
| J1942 | Injection, aripiprazole lauroxil, 1 mg | — | Jan 1, 2017 | Ended Sep 30, 2019 |
| J1943 | Injection, aripiprazole lauroxil, (aristada initio), 1 mg | $3.459per 1 MG | Oct 1, 2019 | Active |
| J1944 | Injection, aripiprazole lauroxil, (aristada), 1 mg | $3.550per 1 MG | Oct 1, 2019 | Active |
| J1945 | Injection, lepirudin, 50 mg | — | Jan 1, 2006 | Ended Dec 31, 2025 |
| J1946 | Injection, furosemide (lasix onyu), 1 mg | — | Oct 1, 2026 | Active |
| J1947 | Injection, furosemide (furoscix), 1 mg | — | Oct 1, 2026 | Active |
| J1950 | Injection, leuprolide acetate (for depot suspension), per 3.75 mg | $1,799.052per 3.75 MG | Jan 1, 1986 | Active |
| J1951 | Injection, leuprolide acetate for depot suspension (fensolvi), 0.25 mg | $141.696per 0.25 MG | Jul 1, 2021 | Active |
| J1952 | Leuprolide injectable, camcevi, 1 mg | $36.373per 1 mg | Jan 1, 2022 | Active |
| J1953 | Injection, levetiracetam, 10 mg | — | Jan 1, 2009 | Ended Sep 30, 2026 |
| J1954 | Injection, leuprolide acetate for depot suspension (lutrate depot), 7.5 mg | $683.860per 7.5 MG | Jan 1, 2023 | Active |
| J1955 | Injection, levocarnitine, per 1 gm | $24.375per 1 GM | Jan 1, 1996 | Active |
| J1956 | Injection, levofloxacin, 250 mg | $2.565per 250 MG | Jan 1, 1999 | Active |
| J1957 | Injection, levetiracetam, 5 mg | $0.013per 5 MG | Oct 1, 2026 | Active |
| J1958 | Injection, levetiracetam in sodium chloride, 5 mg | $0.033per 5 MG | Oct 1, 2026 | Active |
| J1960 | Injection, levorphanol tartrate, up to 2 mg | — | Jan 1, 1982 | Active |